Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04646642 · ClinicalTrials.gov registry record
Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers
A clinical trial, sponsored by David Grant U.S. Air Force Medical Center.
- Completed
- Registry status
- 21
- Enrollment target
NCT04646642: Completed study, sponsored by David Grant U.S. Air Force Medical Center.
NCT04646642 is a clinical trial that has completed, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04646642 has completed, sponsored by David Grant U.S. Air Force Medical Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The proposed research study aims to better understand COVID deployer needs. The study, informally referred to as Project COPE, asks David Grant U.S. Air Force Medical Center (DGMC) members who deployed in support of COVID-19 operations to complete a needs assessment questionnaire. The purpose of this study is to understand the stressful experiences of our COVID Theater Hospital (CTH) deployers, the typical coping strategies used and recommended preferences for support so that the investigators can provide the best evidence-based resources for post-deployment and to aid future CTH deployers.
Primary Outcome
Describe the frequencies of positive screen for depression based on total score \>/= 3 on PHQ-2. The PHQ-2 is a 2-item screening tool for depression that uses first 2 items from PHQ-9. Scale 0 (not at all) to 3 (nearly every day), 0 is better and 3 worse. Total scores exceeding 2 suggest a positive depression screening. This tool provides a brief, practical, valid, and reliable screening instrument.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2021-02-01 |
What the finished NCT04646642 record still lists
NCT04646642 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04646642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04646642 about?
NCT04646642 is a clinical study titled "Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers". The proposed research study aims to better understand COVID deployer needs. The study, informally referred to as Project COPE, asks David Grant U.S. Air Force Medical Center (DGMC) members who deployed in support of COVID-19 operations to complete a needs assessment questionnaire. The purpose of thi...
What is the current status of trial NCT04646642?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2020-12-14. Estimated completion is 2021-02-01.
Who is sponsoring clinical trial NCT04646642?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI